Beyond the brain: widespread pathology in Huntington's disease
- PMID: 19608102
- DOI: 10.1016/S1474-4422(09)70178-4
Beyond the brain: widespread pathology in Huntington's disease
Abstract
Huntington's disease (HD) is an inherited neurodegenerative disorder caused by a polyglutamine stretch in the huntingtin protein. Today, more than 15 years after the genetic defect underlying HD was discovered, the pathogenesis is still not well understood and there is no adequate treatment. Research into this disorder has conventionally focused on neurological symptoms and brain pathology, particularly neurodegeneration in the basal ganglia and cerebral cortex. Mutant huntingtin is, however, ubiquitously expressed throughout the body. Indeed, contrary to earlier thinking, HD is associated with abnormalities in peripheral tissues. These abnormal changes are not all secondary to brain dysfunction, but most seem to be directly caused by expression of mutant huntingtin in peripheral tissues. In this article, we highlight this emerging field of research and how it might affect our understanding of the pathogenesis of this disease, the development of novel biomarkers of disease progression, and the identification of new potential treatments.
Similar articles
-
Huntington's disease: the current state of research with peripheral tissues.Exp Neurol. 2009 Oct;219(2):385-97. doi: 10.1016/j.expneurol.2009.05.012. Epub 2009 May 19. Exp Neurol. 2009. PMID: 19460373 Review.
-
Huntington's disease - neuropathology.Handb Clin Neurol. 2011;100:83-100. doi: 10.1016/B978-0-444-52014-2.00004-5. Handb Clin Neurol. 2011. PMID: 21496571 Review.
-
New Perspectives on the Neuropathology in Huntington's Disease in the Human Brain and its Relation to Symptom Variation.J Huntingtons Dis. 2012;1(2):143-53. doi: 10.3233/JHD-2012-120018. J Huntingtons Dis. 2012. PMID: 25063328 Review.
-
Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease.Neuroscience. 2013 Oct 22;251:66-74. doi: 10.1016/j.neuroscience.2012.05.043. Epub 2012 May 24. Neuroscience. 2013. PMID: 22633949 Review.
-
Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington's disease mutation.Brain Res. 2008 Jan 10;1188:61-8. doi: 10.1016/j.brainres.2007.06.059. Epub 2007 Jul 14. Brain Res. 2008. PMID: 18062944
Cited by
-
Unraveling the complexity of human brain: Structure, function in healthy and disease states.Ageing Res Rev. 2024 Sep;100:102414. doi: 10.1016/j.arr.2024.102414. Epub 2024 Jul 15. Ageing Res Rev. 2024. PMID: 39002647 Review.
-
Brain-Periphery Interactions in Huntington's Disease: Mediators and Lifestyle Interventions.Int J Mol Sci. 2024 Apr 25;25(9):4696. doi: 10.3390/ijms25094696. Int J Mol Sci. 2024. PMID: 38731912 Free PMC article. Review.
-
Dietary fasting and time-restricted eating in Huntington's disease: therapeutic potential and underlying mechanisms.Transl Neurodegener. 2024 Apr 2;13(1):17. doi: 10.1186/s40035-024-00406-z. Transl Neurodegener. 2024. PMID: 38561866 Free PMC article. Review.
-
Retinal dysfunction in Huntington's disease mouse models concurs with local gliosis and microglia activation.Sci Rep. 2024 Feb 20;14(1):4176. doi: 10.1038/s41598-024-54347-8. Sci Rep. 2024. PMID: 38378796 Free PMC article.
-
Lowering mutant huntingtin by small molecules relieves Huntington's disease symptoms and progression.EMBO Mol Med. 2024 Mar;16(3):523-546. doi: 10.1038/s44321-023-00020-y. Epub 2024 Feb 19. EMBO Mol Med. 2024. PMID: 38374466 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
